Wakefield Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,695
Closed -$312K 164
2022
Q3
$312K Buy
+1,695
New +$338K 0.14% 139
2022
Q2
Sell
-11,673
Closed -$2.92M 189
2022
Q1
$2.92M Sell
11,673
-349
-3% -$87.6K 1.05% 29
2021
Q4
$3.09M Buy
12,022
+4
+0% +$979 1.07% 26
2021
Q3
$2.92M Buy
12,018
+289
+2% +$70.7K 1.1% 23
2021
Q2
$2.42M Buy
+11,729
New +$2.39M 0.92% 40

Other funds holding HCA

Wakefield Asset Management's HCA Position: Q4 2022 in Review

Wakefield Asset Management sold out of HCA Healthcare (HCA) in Q4 2022, closing a stake of 1,695 shares — an estimated $312K sold.

Wakefield Asset Management first reported a position in HCA in Q2 2021 and held it in 5 quarters. The position peaked at $3.09M in Q4 2021. 960 funds tracked by Wall St. Rank hold HCA as of Q4 2022.

  • Wakefield Asset Management reported no remaining HCA Healthcare position as of Q4 2022 after selling out during the quarter.
  • Wakefield Asset Management sold 1,695 HCA Healthcare shares in Q4 2022, an estimated $312K.
  • Wakefield Asset Management first reported a position in HCA Healthcare in Q2 2021 and held it in 5 quarters.
  • Wakefield Asset Management's HCA Healthcare position peaked at $3.09M in Q4 2021.
  • 960 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2022.

Based on Wakefield Asset Management's 13F filing for Q4 2022, filed 30 Jan 2023.